|Age:||18 to 65 years old|
|Keywords:||myeloablative allogeneic hematopoietic cell transplantation, hematologic malignancies, blood disoders, cell transplant, blood transfusion, blood donor, blood donation|
|Type:||Biological study, Phase 1|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.